Arrow Greentech Ltd

Arrow Greentech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Arrow Greentech Ltd

₹ 378 -2.55%
20 Mar - close price
arrowgreentech.com BSE: 516064 NSE: ARROWGREEN
About

Incorporated in 1982, Arrow Greentech
Ltd is in the business of bio-degradable (green) products, high-tech products and having Patents income for such products /technology[1]

Key Points

Business Overview:[1][2]
AGL is India’s largest manufacturer of water-soluble films, specializing in the development, production, and marketing of a diverse range of PVA/PVOH-based films. Its portfolio includes innovative applications such as mouth dissolving strips for pharmaceutical and nutraceutical use. In addition to green packaging solutions, AGL also offers advanced security products and intellectual property services, positioning itself as a multi-vertical technology-driven company.

Website BSE NSE
  • Market Cap ₹ 571 Cr.
  • Current Price ₹ 378
  • High / Low ₹ 818 / 342
  • Stock P/E 11.1
  • Book Value ₹ 140
  • Dividend Yield 1.06 %
  • ROCE 53.2 %
  • ROE 39.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 53.4% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 29.2%
  • Debtor days have improved from 70.4 to 44.0 days.
  • Company's working capital requirements have reduced from 97.1 days to 70.0 days

Cons

  • Promoter holding has decreased over last 3 years: -3.79%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Industrials Capital Goods Industrial Products Packaging

Part of BSE Allcap BSE Industrials

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
31 48 44 29 25 51 66 65 55 57 42 61 56
23 30 29 20 18 35 38 39 37 41 27 40 37
Operating Profit 8 19 14 9 7 16 28 26 18 16 14 21 19
OPM % 27% 39% 33% 31% 29% 31% 42% 41% 33% 28% 34% 34% 34%
0 1 1 1 1 1 1 1 2 2 2 2 2
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 2 2 2 2 2 2 2 2 2 2 2 2 2
Profit before tax 6 18 13 8 6 14 27 26 18 16 14 21 19
Tax % 41% 28% 30% 33% 15% 29% 26% 28% 27% 28% 23% 24% 31%
4 13 9 5 5 10 20 19 13 11 11 16 13
EPS in Rs 2.43 8.46 6.19 3.38 3.25 6.71 13.36 12.37 8.52 7.58 7.22 10.43 8.82
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
35 49 51 53 35 34 22 52 34 109 149 243 216
16 19 14 16 29 49 29 44 41 85 102 155 146
Operating Profit 19 29 37 36 5 -14 -7 9 -7 24 47 89 70
OPM % 54% 60% 73% 69% 16% -42% -34% 17% -21% 22% 31% 36% 33%
1 1 5 5 2 1 1 2 2 2 3 5 8
Interest 0 0 0 0 0 0 1 1 1 1 1 0 0
Depreciation 0 1 1 2 4 4 4 5 5 7 8 7 8
Profit before tax 20 30 41 39 3 -17 -10 6 -11 18 41 86 70
Tax % 19% 22% 24% 12% 95% -1% -2% -22% -16% 32% 28% 27%
16 22 31 35 0 -17 -10 7 -9 12 29 63 51
EPS in Rs 11.22 15.84 21.67 24.19 0.19 -11.83 -7.07 4.55 -6.62 8.14 19.56 41.84 34.05
Dividend Payout % 11% 13% 17% 19% 870% -4% 0% 0% 0% 12% 10% 10%
Compounded Sales Growth
10 Years: 17%
5 Years: 62%
3 Years: 93%
TTM: -9%
Compounded Profit Growth
10 Years: 11%
5 Years: 53%
3 Years: 105%
TTM: -17%
Stock Price CAGR
10 Years: -2%
5 Years: 39%
3 Years: 17%
1 Year: -28%
Return on Equity
10 Years: 15%
5 Years: 19%
3 Years: 29%
Last Year: 40%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 12 12 12 12 12 12 14 14 14 15 15 15 15
Reserves 18 35 58 86 86 66 62 70 61 83 112 173 197
0 0 0 0 0 0 5 5 5 3 1 1 3
11 13 16 8 8 9 10 9 9 20 17 19 22
Total Liabilities 41 60 86 106 106 87 92 99 89 121 145 208 236
8 11 16 26 26 23 28 26 28 37 37 38 39
CWIP 1 1 1 1 1 2 10 12 13 1 3 2 1
Investments 7 15 15 18 29 17 14 9 1 0 0 46 76
25 33 53 60 49 45 40 53 46 83 104 123 120
Total Assets 41 60 86 106 106 87 92 99 89 121 145 208 236

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
23 26 27 17 5 -16 3 1 2 3 18 68
-12 -11 -6 -12 -13 8 -24 2 -2 -14 -14 -55
-2 -4 -7 -2 -6 -3 12 -2 -2 8 -4 -4
Net Cash Flow 9 11 14 2 -14 -11 -8 2 -1 -3 1 9

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 5 4 40 66 84 81 56 49 40 88 79 44
Inventory Days 495 78 229 204 84 99 51 127 101 138 66
Days Payable 649 153 267 111 49 80 27 60 68 31 29
Cash Conversion Cycle -149 -71 40 28 178 116 75 73 106 121 187 81
Working Capital Days -39 -68 -35 57 119 116 59 95 112 104 117 70
ROCE % 80% 76% 69% 46% 3% -19% -12% 7% -12% 21% 35% 53%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Employee Benefit Expenses
INR Lakhs ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Total Granted Patents (Cumulative)
Number
Number of Employees
Number
FSSAI Approved Products (Avery Pharma)
Number
Prescription (Rx) Approved Products
Number
Registered Trademarks (India)
Number

Shareholding Pattern

Numbers in percentages

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
68.60% 68.60% 68.60% 68.60% 68.60% 68.60% 66.75% 64.81% 64.81% 64.81% 64.81% 64.81%
0.13% 0.00% 0.02% 0.00% 1.28% 0.21% 0.09% 0.56% 0.27% 0.25% 0.12% 0.14%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.04% 0.11% 0.69% 0.79%
31.28% 31.41% 31.38% 31.42% 30.13% 31.19% 33.16% 34.63% 34.88% 34.84% 34.38% 34.25%
No. of Shareholders 7,7608,2018,13712,63013,43014,83822,32022,03822,60521,68521,94721,521

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Right Issue

Concalls

  • Feb 2026
    Transcript
    AI Summary
    PPT
  • Nov 2025
    Transcript
    AI Summary
    PPT
  • Aug 2025
    Transcript
    AI Summary
    PPT
  • May 2025
    Transcript
    AI Summary
    PPT
  • Feb 2025
    Transcript
    AI Summary
    PPT
  • Oct 2024
    Transcript
    AI Summary
    PPT
  • May 2024
    Transcript
    AI Summary
    PPT
  • May 2024
    Transcript
    AI Summary
    PPT
  • May 2024
    Transcript
    AI Summary
    PPT
  • Feb 2024
    Transcript
    AI Summary
    PPT
  • Nov 2023
    Transcript
    AI Summary
    PPT
  • Jun 2023
    Transcript
    AI Summary
    PPT
  • Nov 2019
    Transcript
    AI Summary
    PPT
  • Feb 2019
    Transcript
    AI Summary
    PPT
  • Aug 2016
    Transcript
    AI Summary
    PPT
  • May 2016
    Transcript
    AI Summary
    PPT
  • Nov 2015
    Transcript
    AI Summary
    PPT
  • Aug 2015
    Transcript
    AI Summary
    PPT